Ofev

Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
IPF
Roche
Esbriet
Pirespa
Boehringer Ingelheim
Ofev
Boehringer Ingelheim preps FDA submission with new data in rare pediatric lung disease
Endpoints
Tue, 09/6/22 - 05:00 pm
Boehringer Ingelheim
nintedanib
Ofev
Boehringer Ingelheim's Ofev nabs FDA nod for expanded use in rare lung disease
Fierce Pharma
Mon, 03/9/20 - 11:19 pm
Boehringer Ingelheim
IPF
Ofev
FDA
ILD
Boehringer bags CHMP backing for Ofev in rare lung disease
Pharmaforum
Mon, 03/2/20 - 10:23 am
Boehringer Ingelheim
Ofev
Europe
CHMP
scleroderma
Boehringer Ingelheim's Ofev cuts rate of decline by 57% in range of rare lung diseases
Fierce Pharma
Tue, 10/1/19 - 10:59 pm
Boehringer Ingelheim
Ofev
idiopathic pulmonary fibrosis
Boehringer Ingelheim’s Ofev secures FDA approval for SSc-ILD
Pharmaceutical Business Review
Mon, 09/9/19 - 10:32 am
Ofev
SSc-ILD
Boehringer Ingelheim
FDA
EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis
First Word Pharma
Mon, 01/19/15 - 12:02 pm
Boehringer Ingelheim
Ofev
IPF
idiopathic pulmonary fibrosis
Europe
Boehringer revs up Ofev sales force, support services to rival Roche's Esbriet in IPF
Fierce Pharma Marketing
Thu, 10/23/14 - 08:41 am
Boehringer Ingelheim
drug reps
Ofev
Roche
Esbriet
IPF
Roche, Boehringer Drugs Wins Approval for Lung Disease
Bloomberg
Wed, 10/15/14 - 04:49 pm
Roche
Boehringer Ingelheim
FDA
IPF
idiopathic pulmonary fibros
Esbriet
Ofev